β-Adrenergic receptor stimulated Ncx1 upregulation is mediated via a CaMKII/AP-1 signaling pathway in adult cardiomyocytes

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 2, 2010, Pages 342-351

  Mani, Santhosh K ^a   Egan, Erin A ^a   Addy, Benjamin K ^a   Grimm, Michael ^c   Kasiganesan, Harinath ^a   Thiyagarajan, Thirumagal ^a   Renaud, Ludivine ^a   Brown, Joan Heller ^c   Kern, Christine B ^b   Menick, Donald R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adrenergic pathway; AP 1; CaMKII; Cardiac hypertrophy; Chromatin immunoprecipitation; Heart failure; Na+ Ca2+ exchanger

Indexed keywords

BETA ADRENERGIC RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HOMODIMER; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C JUN; SODIUM CALCIUM EXCHANGE PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUNB;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HEART MUSCLE CELL; HEART STIMULATION; INTRACELLULAR TRANSPORT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

AGING; ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CATS; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; GENE DELETION; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, CARDIAC; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; SODIUM-CALCIUM EXCHANGER; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 74149093364     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.11.007     Document Type: Article

References (65)

1. 2+ exchanger gene H1-promoter in a transgenic mouse model. Circ. Res. 90 (2002) 158-164
2. 2+ exchanger isoforms NCX1, NCX2, and NCX3 in rat. Am. J. Physiol. 272 (1997) C1250-C1261
3. Barnes K.V., Cheng G., Dawson M.M., and Menick D.R. Cloning of cardiac, kidney, and brain promoters of the feline Ncx1 gene. J. Biol. Chem. 272 (1997) 11510-11517
4. 2+ exchanger expression in adult cardiomyocytes. J. Mol. Cell. Cardiol. 38 (2005) 735-743
5. Xu L., Renaud L., Muller J.G., Baicu C.F., Bonnema D.D., Zhou H., et al. Regulation of Ncx1 expression. Identification of regulatory elements mediating cardiac-specific expression and up-regulation. J. Biol. Chem. 281 (2006) 34430-34440
6. 2+ exchanger in response to cardiac pressure overload. Am. J. Physiol. 265 (1993) H1024-H1029
7. Menick D.R., Barnes K.V., Thacker U.F., Dawson M.M., McDermott D.E., Rozich J.D., et al. The exchanger and cardiac hypertrophy. Ann. N. Y. Acad. Sci. 779 (1996) 489-501
8. 2+ exchange activity in canine pacing-induced heart failure. Circ. Res. 87 (2000) 690-698
9. Pogwizd S.M., Schlotthauer K., Li L., Yuan W., and Bers D.M. Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ. Res. 88 (2001) 1159-1167
10. Sipido K.R., Volders P.G., Vos M.A., and Verdonck F. Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy?. Cardiovasc. Res. 53 (2002) 782-805
11. 2+ cycling proteins underlie cardiac action potential prolongation in a pressure-overloaded guinea pig model with cardiac hypertrophy and failure. Circ. Res. 86 (2000) 558-570
12. 2+ exchange in the infarcted heart. Implications for excitation-contraction coupling. Circ. Res. 81 (1997) 1083-1093
13. 2+-ATPase in failing and nonfailing human myocardium. Circ. Res. 75 (1994) 434-442
14. Hasenfuss G., Meyer M., Schillinger W., Preuss M., Pieske B., and Just H. Calcium handling proteins in the failing human heart. Basic Res. Cardiol. 92 (1997) 87-93
15. Hasenfuss G., Preuss M., Lehnart S., Prestle J., Meyer M., and Just H. Relationship between diastolic function and protein levels of sodium-calcium-exchanger in end-stage failing human hearts. Circulation 94 Suppl 8 (1996) I-443
16. 2+ exchanger in end-stage human heart failure. Circ. Res. 7 (1994) 443-453
17. 2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation 99 (1999) 641-648
18. 2+ exchanger. Circ. Res. 87 (2000) 581-587
19. 2+-exchanger overexpression on excitation-contraction coupling in adult rabbit ventricular myocytes. J. Mol. Cell. Cardiol. 34 (2002) 389-400
20. 2+ exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ. Res. 85 (1999) 1009-1019
21. Bristow M.R. beta-adrenergic receptor blockade in chronic heart failure. Circulation 101 (2000) 558-569
22. Vatner S.F., Vatner D.E., and Homcy C.J. Beta-adrenergic receptor signaling: an acute compensatory adjustment-inappropriate for the chronic stress of heart failure? Insights from Gsalpha overexpression and other genetically engineered animal models. Circ. Res. 86 (2000) 502-506
23. Lowes B.D., Gilbert E.M., Abraham W.T., Minobe W.A., Larrabee P., Ferguson D., et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N. Engl. J. Med. 346 (2002) 1357-1365
24. Rothermel B.A., McKinsey T.A., Vega R.B., Nicol R.L., Mammen P., Yang J., et al. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 3328-3333
25. Sucharov C.C., Mariner P.D., Nunley K.R., Long C., Leinwand L., and Bristow M.R. A beta1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction. Am. J. Physiol. Heart Circ. Physiol. 29 (2006) H1299-H1308
26. Golden K.L., Ren J., O'Connor J., Dean A., DiCarlo S.E., and Marsh J.D. In vivo regulation of Na/Ca exchanger expression by adrenergic effectors. Am. J. Physiol. Heart Circ. Physiol. 280 (2001) H1376-H1382
27. 2+Exchanger expression in rat cardiac myocytes. J. Mol. Cell. Cardiol. 32 (2000) 611-620
28. Kent R.L., Mann D.L., Urabe Y., Hisano R., Hewett K.W., Loughnane M., et al. Contractile function of isolated feline cardiocytes in response to viscous loading. Am. J. Physiol. 257 (1989) H1717-H1727
29. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., and Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 2509-2514
30. 2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J. Clin. Invest. 119 (2009) 1230-1240
31. Morisco C., Zebrowski D.C., Vatner D.E., Vatner S.F., and Sadoshima J. Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart. J. Mol. Cell. Cardiol. 33 (2001) 561-573
32. Bers D.M., and Ziolo M.T. When is cAMP not cAMP? Effects of compartmentalization. Circ. Res. 89 (2001) 373-375
33. Zolk O., Marx M., Jackel E., El-Armouche A., and Eschenhagen T. Beta-adrenergic stimulation induces cardiac ankyrin repeat protein expression: involvement of protein kinase A and calmodulin-dependent kinase. Cardiovasc. Res. 59 (2003) 563-572
34. 2+/calmodulin kinase signaling pathway. Circ. Res. 95 (2004) 798-806
35. Zhu W.Z., Wang S.Q., Chakir K., Yang D., Zhang T., Brown J.H., et al. Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J. Clin. Invest. 111 (2003) 617-625
36. Manna P.R., and Stocco D.M. Crosstalk of CREB and Fos/Jun on a single cis-element: transcriptional repression of the steroidogenic acute regulatory protein gene. J. Mol. Endocrinol. 39 (2007) 261-277
37. Rutberg S.E., Adams T.L., Olive M., Alexander N., Vinson C., and Yuspa S.H. CRE DNA binding proteins bind to the AP-1 target sequence and suppress AP-1 transcriptional activity in mouse keratinocytes. Oncogene 18 (1999) 1569-1579
38. Yamamoto K.K., Gonzalez G.A., Biggs III W.H., and Montminy M.R. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334 (1988) 494-498
39. Xing J., Ginty D.D., and Greenberg M.E. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273 (1996) 959-963
40. Du K., and Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 273 (1998) 32377-32379
41. Thonberg H., Fredriksson J.M., Nedergaard J., and Cannon B. A novel pathway for adrenergic stimulation of cAMP-response-element-binding protein (CREB) phosphorylation: mediation via alpha1-adrenoceptors and protein kinase C activation. Biochem. J. 364 (2002) 73-79
42. Sun P., Enslen H., Myung P.S., and Maurer R.A. Differential activation of CREB by Ca2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev. 8 (1994) 2527-2539
43. Zayzafoon M., Fulzele K., and McDonald J.M. Calmodulin and calmodulin-dependent kinase IIalpha regulate osteoblast differentiation by controlling c-fos expression. J. Biol. Chem. 280 (2005) 7049-7059
44. Mishra J.P., Mishra S., Gee K., and Kumar A. Differential involvement of calmodulin-dependent protein kinase II-activated AP-1 and c-Jun N-terminal kinase-activated EGR-1 signaling pathways in tumor necrosis factor-alpha and lipopolysaccharide-induced CD44 expression in human monocytic cells. J. Biol. Chem. 280 (2005) 26825-26837
45. 2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells. Cell. Signal. 20 (2008) 613-624
46. Luttrell L.M. Composition and function of g protein-coupled receptor signalsomes controlling mitogen-activated protein kinase activity. J. Mol. Neurosci. 26 (2005) 253-264
47. Zheng M., Zhang S.J., Zhu W.Z., Ziman B., Kobilka B.K., and Xiao R.P. beta 2-adrenergic receptor-induced p38 MAPK activation is mediated by protein kinase A rather than by Gi or gbeta gamma in adult mouse cardiomyocytes. J. Biol. Chem. 275 (2000) 40635-40640
48. Zechner D., Thuerauf D.J., Hanford D.S., McDonough P.M., and Glembotski C.C. A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J. Cell. Biol. 139 (1997) 115-127
49. Wang Y., Huang S., Sah V.P., Ross Jr. J., Brown J.H., Han J., et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J. Biol. Chem. 273 (1998) 2161-2168
50. Zechner D., Craig R., Hanford D.S., McDonough P.M., Sabbadini R.A., and Glembotski C.C. MKK6 activates myocardial cell NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. J. Biol. Chem. 273 (1998) 8232-8239
51. Maier L.S., and Bers D.M. Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond. J. Mol. Cell. Cardiol. 34 (2002) 919-939
52. Tobimatsu T., and Fujisawa H. Tissue-specific expression of four types of rat calmodulin-dependent protein kinase II mRNAs. J. Biol. Chem. 264 (1989) 17907-17912
53. 2+-ATPase activity in guinea pig ventricles. J. Biol. Chem. 258 (1983) 464-471
54. Takasago T., Imagawa T., and Shigekawa M. Phosphorylation of the cardiac ryanodine receptor by cAMP-dependent protein kinase. J. Biochem. 106 (1989) 872-877
55. 2+/calmodulin-dependent protein kinases of cardiac sarcoplasmic reticulum. Basic Res. Cardiol. 92 (1997) 37-43
56. Wagner S., Dybkova N., Rasenack E.C., Jacobshagen C., Fabritz L., Kirchhof P., et al. Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels. J. Clin. Invest. 116 (2006) 3127-3138
57. Zhang T., Maier L.S., Dalton N.D., Miyamoto S., Ross Jr. J., Bers D.M., et al. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ. Res. 92 (2003) 912-919
58. 2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ. Res. 84 (1999) 713-721
59. 2+ ATPase transport capacity regulates the contractility of normal and hypertrophied feline ventricular myocytes. J. Card. Fail. 11 (2005) 380-387
60. Anderson M.E. Calmodulin kinase and L-type calcium channels; a recipe for arrhythmias?. Trends Cardiovasc. Med. 14 (2004) 152-161
61. 2+-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 252 (1991) 1427-1430
62. Masquilier D., and Sassone-Corsi P. Transcriptional cross-talk: nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation by Jun. J. Biol. Chem. 267 (1992) 22460-22466
63. Mechta-Grigoriou F., Gerald D., and Yaniv M. The mammalian Jun proteins: redundancy and specificity. Oncogene 20 (2001) 2378-2389
64. Tsai L.N., Ku T.K., Salib N.K., and Crowe D.L. Extracellular signals regulate rapid coactivator recruitment at AP-1 sites by altered phosphorylation of both CREB binding protein and c-jun. Mol. Cell. Biol. 28 (2008) 4240-4250
65. Backs J., Song K., Bezprozvannaya S., Chang S., Olson E.N., and CaM kinase I.I. selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J. Clin. Invest. 116 (2006) 1853-1864